Literature DB >> 15073090

Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms.

Ying Li1, Bernhard Zimmermann, Corinne Rusterholz, Anjeung Kang, Wolfgang Holzgreve, Sinuhe Hahn.   

Abstract

BACKGROUND: Analysis of fetal DNA in maternal plasma has recently been introduced as a new method for noninvasive prenatal diagnosis, particularly for the analysis of fetal genetic traits, which are absent from the maternal genome, e.g., RHD or Y-chromosome-specific sequences. To date, the analysis of other fetal genetic traits has been more problematic because of the overwhelming presence of maternal DNA sequences in the circulation. We examined whether different biochemical properties can be discerned between fetal and maternal circulatory DNA.
METHODS: Plasma DNA was examined by agarose gel electrophoresis. The fractions of fetal and maternal DNA in size-fractionated fragments were assayed by real-time PCR. The determination of paternally and maternally inherited fetal genetic traits was examined by use of highly polymorphic chromosome-21-specific microsatellite markers.
RESULTS: Size fractionation of circulatory DNA indicated that the major portion of cell-free fetal DNA had an approximate molecular size of <0.3 kb, whereas maternally derived sequences were, on average, considerably larger than 1 kb. Analysis of size-fractionated DNA (</=0.3 kb) from maternal plasma samples facilitated the ready detection of paternally and maternally inherited microsatellite markers.
CONCLUSIONS: Circulatory fetal DNA can be enriched by size selection of fragment sizes less than approximately 0.3 kb. Such selection permits easier analysis of both paternally and maternally inherited DNA polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073090     DOI: 10.1373/clinchem.2003.029835

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  50 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

Review 2.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

3.  Digital PCR for the molecular detection of fetal chromosomal aneuploidy.

Authors:  Y M Dennis Lo; Fiona M F Lun; K C Allen Chan; Nancy B Y Tsui; Ka C Chong; Tze K Lau; Tak Y Leung; Benny C Y Zee; Charles R Cantor; Rossa W K Chiu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

4.  Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia.

Authors:  Aaron F Orozco; Carolina J Jorgez; Cassandra Horne; Deborah A Marquez-Do; Matthew R Chapman; John R Rodgers; Farideh Z Bischoff; Dorothy E Lewis
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

5.  Improving enrichment of circulating fetal DNA for genetic testing: size fractionation followed by whole gene amplification.

Authors:  Carolina J Jorgez; Farideh Z Bischoff
Journal:  Fetal Diagn Ther       Date:  2009-09-22       Impact factor: 2.587

6.  Sequencing of short cfDNA fragments in NIPT improves fetal fraction with higher maternal BMI and early gestational age.

Authors:  Longwei Qiao; Qin Zhang; Yuting Liang; Ang Gao; Yang Ding; Nannan Zhao; Wei Zhang; Hong Li; Yaojuan Lu; Ting Wang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

7.  An SNP panel for the analysis of paternally inherited alleles in maternal plasma using ion Torrent PGM.

Authors:  Donggui Yang; Hao Liang; Shaobin Lin; Qing Li; Xiaoyan Ma; Jun Gao; Hongyu Sun; Qingqing Chen; Jianzhu Wu; Xueling Ou
Journal:  Int J Legal Med       Date:  2017-04-20       Impact factor: 2.686

Review 8.  Non-invasive Prenatal Testing Using Fetal DNA.

Authors:  Giulia Breveglieri; Elisabetta D'Aversa; Alessia Finotti; Monica Borgatti
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

9.  Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer.

Authors:  Ramin Radpour; Zeinab Barekati; Corina Kohler; Qing Lv; Nicole Bürki; Claude Diesch; Johannes Bitzer; Hong Zheng; Seraina Schmid; Xiao Yan Zhong
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

10.  Optimized quantification of fragmented, free circulating DNA in human blood plasma using a calibrated duplex real-time PCR.

Authors:  Martin Horlitz; Annabelle Lucas; Markus Sprenger-Haussels
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.